NCT05731453View on ClinicalTrials.gov

Clinical Pilot Study for Personalized Risk-based Breast Cancer Screening

NAActive, not recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

May 1, 2024

Study Completion Date

November 11, 2035

Conditions
Breast Cancer
Interventions
GENETIC

Polygenetic risk score

Polygenetic risk score assessment for breast cancer

Trial Locations (1)

Unknown

Vestre Viken Hospital Trust, Drammen

All Listed Sponsors
collaborator

Oslo University Hospital

OTHER

lead

Vestre Viken Hospital Trust

OTHER